
  Mrv0541 02231215442D          

 10 10  0  0  1  0            999 V2000
    1.4289   -1.6500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7145   -1.2375    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000   -1.6500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7145   -0.4125    0.0000 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.0000    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0000    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7145    1.2375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7145    2.0625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4289    0.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4289    0.0000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  2  3  1  0  0  0  0
  4  2  1  6  0  0  0
  4  5  1  0  0  0  0
  5  6  1  0  0  0  0
  6  7  1  0  0  0  0
  7  8  1  0  0  0  0
  7  9  2  0  0  0  0
  9 10  1  0  0  0  0
  4 10  1  0  0  0  0
M  END
> <DRUGBANK_ID>
DB01802

> <DRUG_GROUPS>
experimental

> <GENERIC_NAME>
(4r)-7aza-7,8-Dihydrolimonene

> <CHEMICAL_FORMULA>
C9H17N

> <MOLECULAR_WEIGHT>
139.238

> <EXACT_MASS>
139.136099549

> <IUPAC_NAME>
(1R)-N,N,4-trimethylcyclohex-3-en-1-amine

> <IUPAC_TRADITIONAL_NAME>
(1R)-N,N,4-trimethylcyclohex-3-en-1-amine

> <INCHI_IDENTIFIER>
InChI=1S/C9H17N/c1-8-4-6-9(7-5-8)10(2)3/h4,9H,5-7H2,1-3H3/t9-/m0/s1

> <INCHI_KEY>
InChIKey=LDFVYCXKPXXSNO-VIFPVBQESA-N

> <SMILES>
CN(C)[C@@H]1CCC(C)=CC1

> <JCHEM_ACCEPTOR_COUNT>
1

> <JCHEM_DONOR_COUNT>
0

> <JCHEM_BASIC_PKA>
10.16

> <JCHEM_PHYSIOLOGICAL_CHARGE>
1

> <ALOGPS_LOGP>
2.09

> <JCHEM_LOGP>
1.87

> <ALOGPS_LOGS>
-0.27

> <JCHEM_POLARIZABILITY>
17.7

> <JCHEM_POLAR_SURFACE_AREA>
3.24

> <JCHEM_REFRACTIVITY>
46.4

> <JCHEM_ROTATABLE_BOND_COUNT>
1

> <ALOGPS_SOLUBILITY>
7.44e+01 g/l __ 

$$$$
